Table 2 Clinicopathological information of 4 basal cell adenocarcinoma cases
Case No. | Sex | Origin | Size (mm) | TLE1 (nuclear) | β-catenin (nuclear) | Ki67 | Mitosis (/10HPF) | CTNNB1 Mutation | Prognosis (months) |
|---|---|---|---|---|---|---|---|---|---|
1 | F | P | 20 | luminal cell ++, but indistinct at infiltrative areas | abluminal cell ++ | 9.0% | 3/10 | + | Alive (18) |
2 | F | P | 40 | luminal cell +, but indistinct at infiltrative areas | abluminal cell ++ | 4.7% | 4/10 | + | Alive (24) |
3 | F | P | 15 | luminal cell ++ | abluminal cell + | 5.3% | 4/10 | – | Alive (60) |
4 | F | P | 53 | luminal cell ++ indistinct at infiltrative areas | abluminal cell ++ | 7.6% | 9/10 | – | Alive (1) |